CME Questions

May 2010
Internal Medicine Alert;5/15/2010, Vol. 32 Issue 9, p70
A quiz concerning several medical topics including superficial venous thrombosis, reduction in cancer mortality, atrial fibrillation is presented.


Related Articles

  • The Janus face of thromboprophylaxis in patients with high risk for both thrombosis and bleeding during intracranial surgery: report of five exemplary cases. Niemi, Tomi; Silvasti-Lundell, Marja; Armstrong, Elina; Hernesniemi, Juha // Acta Neurochirurgica;Oct2009, Vol. 151 Issue 10, p1289 

    The antithrombotic agents are usually interrupted in fear of bleeding complications before neurosurgery. However, the optimal schematic regimen of substitutive medication to prevent thromboembolic events after surgery is unsettled. We report five complex neurosurgical cases with high risk for...

  • Thrombus in transit through a patent foramen ovale. Abdelsalam, Murad; Mumtaz, Mubashir; Sackman, Ira // Heart;Aug2012, Vol. 98 Issue 16, p1184 

    The article presents a case study of an obese 57-year-old woman who was suffering from shortness of breath and palpitation. The diagnostic result showed rapid atrial fibrillation with a heart rate of about 178 beats per minute and blood pressure, 120/60 millimeter of mercury. Ultrasound result...

  • Rivaroxaban: An oral direct inhibitor of factor Xa. Gulseth, Michael P.; Michaud, Jessica; Nutescu, Edith A. // American Journal of Health-System Pharmacy;8/15/2008, Vol. 65 Issue 16, p1520 

    Purpose. The mechanism of action, pharmacodynamics, pharmacokinetics, efficacy in clinical trials, interactions, adverse effects and toxicity, and place in therapy of rivaroxaban are reviewed. Summary. Rivaroxaban, the first oral, direct factor Xa (FXa) inhibitor to reach Phase III trials,...

  • How to manage warfarin therapy. Tideman, Philip A.; Tirimacco, Rosy; John, Andrew St; Roberts, Gregory W. // Australian Prescriber;Apr2015, Vol. 38 Issue 2, p44 

    Long-term treatment with warfarin is recommended for patients with atrial fibrillation at risk of stroke and those with recurrent venous thrombosis or prosthetic heart valves. Patient education before commencing warfarin - regarding signs and symptoms of bleeding, the impact of diet, potential...

  • Abstracts.  // Research & Practice In Thrombosis & Haemostasis;Jul2019 Supplement S1, Vol. 3, p1 

    No abstract available.

  • Further Issues with New Oral Anticoagulants. Huisman, M. V. // Current Pharmaceutical Design;10/21/2010, Vol. 16 Issue 31, p3487 

    No abstract available.

  • Längere venöse Thromboembolie-Prophylaxe mit Apixaban vs. kürzere mit Enoxaparin bei kritisch Kranken nicht überlegen. Woitzek, Katja // Praxis (16618157);6/6/2012, Vol. 101 Issue 11, p745 

    No abstract available.

  • An unusual presentation of pulmonary artery dissection. S L Hoye // Thorax;Apr2009, Vol. 64 Issue 4, p368 

    The article focuses on the uncommon presentation of pulmonary artery dissection in an obese woman. It says that the patient had a history of venous thrombosis and atrial fibrillation and type 2 respiratory failure. It mentions several analyses conducted including spirometry, echocardiography and...

  • AMPLIFY trial results.  // Hospital Medicine Alert;Sep2013 Pharmacology Watch, p2 

    The article discusses research done on the effects of apixaban and anticoagulant therapy in patients with acute venous thromboembolism (VTE) published online in the July 1, 2013 issue of the "New England Journal of Medicine."


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics